サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1084055

うつ病治療の世界市場（2022年～2028年）：製品タイプ別、疾患別、地域別の市場規模調査と予測

Global Depression Treatment Market Size study, By Product Type, By Disease (Major Depression, Persistent Depressive Disorder, Seasonal Affective Disorder, Situational Depression, Treatment-Resistant Depression, Others), & Regional Forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
うつ病治療の世界市場（2022年～2028年）：製品タイプ別、疾患別、地域別の市場規模調査と予測
出版日: 2022年05月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のうつ病治療の市場規模は、2022年～2028年の予測期間中に健全な成長率で成長すると予想されています。市場を牽引する主な要因には、うつ病の発生率の上昇、精神状態を治すための治療法や抗うつ薬の需要の高まり、医療費の増加などがあります。しかし、薬剤の副作用や治療における必要な間隔が、予測期間における市場の成長を阻害しています。また、精神障害の経済的負担の増加や幅広い治療オプションの利用可能性が、予測期間中の市場需要の触媒として作用すると予測されます。

当レポートでは世界のうつ病治療市場を調査し、市場の概要、市場の促進要因・抑制要因の分析、市場機会、COVID-19の影響、セグメント別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界のうつ病治療市場：定義と範囲

第3章 世界のうつ病治療：市場力学

  • うつ病治療市場：影響分析（2020年～2028年）

第4章 世界のうつ病治療市場：業界分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要な投資機会
  • 主要な成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19以前およびCOVID-19後の市場シナリオ

第6章 世界のうつ病治療市場：製品タイプ別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 薬剤
    • TMSデバイス

第7章 世界のうつ病治療市場：疾患別

  • 市場のスナップショット
  • 実績：潜在的な分析
  • 市場規模の推計と予測（2018年～2028年）
  • サブセグメント分析
    • 大うつ病
    • 持続性抑うつ障害
    • 季節性情動障害（SAD）
    • 状況的うつ病
    • 治療抵抗性うつ病
    • その他

第8章 世界のうつ病治療市場：地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州のスナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第9章 競合情勢

  • 主な市場戦略
  • 企業プロファイル
    • Viatris (Mylan Pharmaceuticals Inc.)
    • Sunovion Pharmaceuticals
    • AbbVie Inc. (Allergan, Inc.)
    • Jubilant Generics Limited
    • Sanis Health Inc.
    • (Apotex Holdings, Inc.) Apotex Corporation
    • Alembic Pharmaceuticals Limited
    • Pfizer Inc.
    • BrainsWay Ltd.
    • Nexstim Plc

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Depression Treatment Market, report scope
  • TABLE 2. Global Depression Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)
  • TABLE 3. Global Depression Treatment Market estimates & forecasts by Product Type 2018-2028 (USD Million)
  • TABLE 4. Global Depression Treatment Market estimates & forecasts by Disease 2018-2028 (USD Million)
  • TABLE 5. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 6. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 7. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 8. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 9. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 10. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 11. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 12. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 13. Global Depression Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 14. Global Depression Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 15. U.S. Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 16. U.S. Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 17. U.S. Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 18. Canada Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 19. Canada Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 20. Canada Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 21. UK Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 22. UK Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 23. UK Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 24. Germany Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 25. Germany Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 26. Germany Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 27. RoE Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 28. RoE Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 29. RoE Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 30. China Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 31. China Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 32. China Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 33. India Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 34. India Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 35. India Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 36. Japan Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 37. Japan Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 38. Japan Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 39. RoAPAC Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 40. RoAPAC Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 41. RoAPAC Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 42. Brazil Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 43. Brazil Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 44. Brazil Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 45. Mexico Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 46. Mexico Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 47. Mexico Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 48. RoLA Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 49. RoLA Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 50. RoLA Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 51. Row Depression Treatment Market estimates & forecasts, 2018-2028 (USD Million)
  • TABLE 52. Row Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 53. Row Depression Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
  • TABLE 54. List of secondary sources, used in the study of global Depression Treatment Market
  • TABLE 55. List of primary sources, used in the study of global Depression Treatment Market
  • TABLE 56. Years considered for the study
  • TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Depression Treatment Market, research methodology
  • FIG 2. Global Depression Treatment Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Depression Treatment Market, key trends 2021
  • FIG 5. Global Depression Treatment Market, growth prospects 2022-2028
  • FIG 6. Global Depression Treatment Market, porters 5 force model
  • FIG 7. Global Depression Treatment Market, pest analysis
  • FIG 8. Global Depression Treatment Market, value chain analysis
  • FIG 9. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 10. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 11. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 12. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 13. Global Depression Treatment Market by segment, 2018 & 2028 (USD Million)
  • FIG 14. Global Depression Treatment Market, regional snapshot 2018 & 2028
  • FIG 15. North America Depression Treatment Market 2018 & 2028 (USD Million)
  • FIG 16. Europe Depression Treatment Market 2018 & 2028 (USD Million)
  • FIG 17. Asia Pacific Depression Treatment market 2018 & 2028 (USD Million)
  • FIG 18. Latin America Depression Treatment Market 2018 & 2028 (USD Million)
  • FIG 19. Global Depression Treatment Market, company market share analysis (2021)
目次

Global Depression Treatment Market is valued at approximately USDXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Depression is a health condition in which an individual's mood is elevated or lower which causes a loss of interest and persistent feeling of sadness. Depression treatment includes medication, consulting therapy, or a combination of both. The rising incidences of depression worldwide, the growing need for therapies and antidepressants for curing mental conditions, coupled with increasing healthcare expenditure are the primary factors excelling the global market demand. For instance, according to Statista analysis, in 2020, nearly 2.1 million cases of depression among senior citizens were registered in India. Also, the figure is anticipated to rise and reach around 5 million cases of depression among senior citizens. Accordingly, the rapidly growing cases of depression among the global population are accelerating the demand for depression treatment, which is augmenting the market growth around the world. However, adverse effects of drugs and necessary gaps in treatment impede the growth of the market over the forecast period of 2022-2028. Also, the rising economic burden of mental disorders and the availability of a wide range of treatment options are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Depression Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the rising prevalence of various depression and anxiety disorders, along with the availability of skilled professionals. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the growing population, as well as rising investment in the R&D activities for the development of antidepressant drugs, would create lucrative growth prospects for the Depression Treatment Market across the Asia-Pacific region.

Major market players included in this report are:

Viatris (Mylan Pharmaceuticals Inc.)

Sunovion Pharmaceuticals

AbbVie Inc. (Allergan, Inc.)

Jubilant Generics Limited

Sanis Health Inc.

(Apotex Holdings, Inc.) Apotex Corporation

Alembic Pharmaceuticals Limited

Pfizer Inc.

BrainsWay Ltd.

Nexstim Plc

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:

Drugs

TMS Devices

By Disease:

Major Depression

Persistent Depressive Disorder

Seasonal Affective Disorder (SAD)

Situational Depression

Treatment-Resistant Depression

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Depression Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
    • 1.2.1. Depression Treatment Market, by Region, 2020-2028 (USD Million)
    • 1.2.2. Depression Treatment Market, by Product Type, 2020-2028 (USD Million)
    • 1.2.3. Depression Treatment Market, by Disease, 2020-2028 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Depression Treatment Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Depression Treatment Market Dynamics

  • 3.1. Depression Treatment Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising incidences of depression worldwide
      • 3.1.1.2. Increasing healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. Adverse effects of drugs and necessary gaps in treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising economic burden of mental disorders
      • 3.1.3.2. Availability of a wide-range of treatment options

Chapter 4. Global Depression Treatment Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Depression Treatment Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Depression Treatment Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Depression Treatment Market Estimates & Forecasts by Product Type, 2018-2028 (USD Million)
  • 6.4. Depression Treatment Market, Sub Segment Analysis
    • 6.4.1. Drugs
    • 6.4.2. TMS Devices

Chapter 7. Global Depression Treatment Market, by Disease

  • 7.1. Market Snapshot
  • 7.2. Global Depression Treatment Market by Disease, Performance - Potential Analysis
  • 7.3. Global Depression Treatment Market Estimates & Forecasts by Disease, 2018-2028 (USD Million)
  • 7.4. Depression Treatment Market, Sub Segment Analysis
    • 7.4.1. Major Depression
    • 7.4.2. Persistent Depressive Disorder
    • 7.4.3. Seasonal Affective Disorder (SAD)
    • 7.4.4. Situational Depression
    • 7.4.5. Treatment-Resistant Depression
    • 7.4.6. Others

Chapter 8. Global Depression Treatment Market, Regional Analysis

  • 8.1. Depression Treatment Market, Regional Market Snapshot
  • 8.2. North America Depression Treatment Market
    • 8.2.1. U.S. Depression Treatment Market
      • 8.2.1.1. Product Type breakdown estimates & forecasts, 2018-2028
      • 8.2.1.2. Disease breakdown estimates & forecasts, 2018-2028
    • 8.2.2. Canada Depression Treatment Market
  • 8.3. Europe Depression Treatment Market Snapshot
    • 8.3.1. U.K. Depression Treatment Market
    • 8.3.2. Germany Depression Treatment Market
    • 8.3.3. France Depression Treatment Market
    • 8.3.4. Spain Depression Treatment Market
    • 8.3.5. Italy Depression Treatment Market
    • 8.3.6. Rest of Europe Depression Treatment Market
  • 8.4. Asia-Pacific Depression Treatment Market Snapshot
    • 8.4.1. China Depression Treatment Market
    • 8.4.2. India Depression Treatment Market
    • 8.4.3. Japan Depression Treatment Market
    • 8.4.4. Australia Depression Treatment Market
    • 8.4.5. South Korea Depression Treatment Market
    • 8.4.6. Rest of Asia Pacific Depression Treatment Market
  • 8.5. Latin America Depression Treatment Market Snapshot
    • 8.5.1. Brazil Depression Treatment Market
    • 8.5.2. Mexico Depression Treatment Market
  • 8.6. Rest of The World Depression Treatment Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Viatris (Mylan Pharmaceuticals Inc.)
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Sunovion Pharmaceuticals
    • 9.2.3. AbbVie Inc. (Allergan, Inc.)
    • 9.2.4. Jubilant Generics Limited
    • 9.2.5. Sanis Health Inc.
    • 9.2.6. (Apotex Holdings, Inc.) Apotex Corporation
    • 9.2.7. Alembic Pharmaceuticals Limited
    • 9.2.8. Pfizer Inc.
    • 9.2.9. BrainsWay Ltd.
    • 9.2.10. Nexstim Plc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption